FIELD: medicine; pharmacology.
SUBSTANCE: group of inventions refers to pharmacology and medicine. Bactericidal pharmaceutical composition comprising the following items was proposed: (a) 1 or 2 mcg/ml cefixime or its pharmaceutically acceptable salt, (b) 4 mcg/ml clavulanic acid or its pharmaceutically acceptable salt and (c) 2 mcg/ml of mecillinam; the bactericidal pharmaceutical composition comprising the following: (a) 1 or 2 mcg/ml of cefuroxime or its pharmaceutically acceptable salt, (b) 4 mcg/ml of clavulanic acid or its pharmaceutically acceptable salt and and (c) 2 mcg/ml of mecillinam, and the bactericidal pharmaceutical composition comprising the following: (a) 1 or 2 mcg/ml of cefpodoxime or its pharmaceutically acceptable salt, (b) 4 mcg/ml of clavulanic acid or its pharmaceutically acceptable salt and and (c) 2 mcg/ml of mecillinam.
EFFECT: technical result consists in the effectiveness of the claimed compositions against the highly resistant pathogen, the Klebsiella pneumoniae strain, producing ESBL SHV and TEM.
3 cl, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS OF TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2676482C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING BETA-LACTAM ANTIBIOTIC, SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2569059C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING BACTERIAL INFECTIONS CAUSED BY THE MAIN PATHOGENS | 2023 |
|
RU2825961C1 |
NITROGEN-CONTAINING COMPOUNDS AND APPLICATION THEREOF | 2012 |
|
RU2569307C1 |
ORALLY ADMINISTERED COMBINATIONS OF BETA-LACTAM ANTIBIOTICS AND AVIBACTAM DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | 2020 |
|
RU2825281C1 |
MEDICATION FOR TREATMENT OF INFECTIOS DISEASES | 2010 |
|
RU2424801C1 |
CYCLIC BORONIC ACID ESTER DERIVATIVES AND THERAPEUTIC USE THEREOF | 2011 |
|
RU2599791C2 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND THEIR APPLICATION FOR BACTERIAL INFECTIONS TREATMENT | 2012 |
|
RU2636147C1 |
1,6-DIAZABICYCLO[3,2,1]OCTAN-7-ONE DERIVATIVES AND USING THEM FOR TREATING BACTERIAL INFECTIONS | 2012 |
|
RU2578370C2 |
PHARMACEUTICAL COMPOSITIONS, CONTAINING SULBACTAM AND BETA-LACTAMASE INHIBITOR | 2011 |
|
RU2560846C1 |
Authors
Dates
2018-03-07—Published
2013-05-13—Filed